Article
Stopping Disputes Before They Derail Innovation: The Emerging Role Of Life Sciences Dispute Review Boards
The American Arbitration Association has introduced Life Sciences Dispute Review Boards to help pharmaceutical, biotech, and medical device companies resolve technical disagreements before they escalate into costly formal disputes. These standing panels of neutral experts can address complex issues in licensing, R&D, and manufacturing agreements, but they involve recurring costs and strategic considerations around confidentiality, privilege, and the admissibility of recommendations in later proceedings.
United States
Litigation